The Interdisciplinary Stem Cell Institute (ISCI) is one of the nation’s top regenerative medicine research facilities that is revolutionizing the treatment of disease through stem cell therapies. Director Joshua M. Hare, M.D. is at the helm of this uniquely integrated research community composed of an interdisciplinary team of the country’s top scientists and physicians formed by more than 70 ISCI members representing 16 academic departments at the University of Miami Miller School of Medicine. Through advanced stem cell research, ISCI is one of the few institutes to advance laboratory findings to clinical trials and emerging therapies. It is at the forefront of using adult mesenchymal stem cells for the repair of malfunctioning human organ and is leading the nation in research for cardiovascular stem cell therapies. Using a multi-disciplinary approach, ISCI engages the 70+ members to provide a collaborative foundation, combining stem cell biology with other sciences to find new solutions and treatments.
ISCI conducts meticulous, ground-breaking research to find new treatments for heart disease, neurological disease, bone disease, diabetes, cancer, eye diseases and other chronic, debilitating or incurable diseases. Their trial results have been published in prestigious medical journals, including Journal of the American Medical Association and the Journal of The American Heart Association. ISCI has launched a series of first-ever U.S. clinical trials in a variety of clinical areas including Aging Frailty, Gastroenterology – Crohn’s and Colitis, Pediatric Cardiology – Hypoplastic Left Heart Syndrome, Psychology – Treatment Resistant Depression and Pulmonology – Idiopathic Pulmonary Fibrosis.http://isci.med.miami.edu/